Satellos Bioscience (STU:0IT) Moat Score: 2/10 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:0IT Satellos Bioscience Inc STU:0IT
35 GF Score
Price €8.00
! 1 Warning Sign
View Full Analysis

What is Satellos Bioscience Moat Score?

Satellos Bioscience STU:0IT -1.84% 35 Moat Score is 2 as of Jul. 14, 2026. GuruFocus rates STU:0IT with a GF Score™ of 35/100. The stock has 1 warning sign investors should review. Among 1,396 Biotechnology companies, Satellos Bioscience ranks better than 58.31% on this metric.

Satellos Bioscience has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Satellos Bioscience has No Moat: Satellos Bioscience Inc has limited market presence and lacks significant network effects or intellectual property. The company does not possess strong brand strength or durable cost advantages, resulting in a weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Satellos Bioscience might have No Moat - Very weak/transient advantages.

Satellos Bioscience  (STU:0IT) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Satellos Bioscience Moat Score Related Terms

STU:0IT vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, Satellos Bioscience's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Satellos Bioscience Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Satellos Bioscience's Moat Score distribution charts can be found below:

* The bar in red indicates where Satellos Bioscience's Moat Score falls into.


STU:0IT
35GF Score
Satellos Bioscience Inc STU:0IT
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Satellos Bioscience (STU:0IT) has a Moat Score of 2 as of Jul. 14, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Satellos Bioscience ranks #582 out of 1396 companies in the Biotechnology industry, placing it in the top 41.7%.
Is Satellos Bioscience's Moat Score too high?
Satellos Bioscience's current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. Satellos Bioscience's value of 2 is 0% at this industry median. Based on the distribution chart, Satellos Bioscience ranks #582 out of 1396 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Satellos Bioscience has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Satellos Bioscience's Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Satellos Bioscience ranks #582 out of 1396 companies for Moat Score. This puts Satellos Bioscience in the upper half of its industry. The industry median Moat Score is 2.00. Satellos Bioscience's value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,396 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Satellos Bioscience's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Satellos Bioscience's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Satellos Bioscience stock overvalued right now?
Satellos Bioscience (STU:0IT) has a current Moat Score of 2. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. Satellos Bioscience's overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Satellos Bioscience (STU:0IT), the current Moat Score is 2 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Satellos Bioscience Business Description

Address 200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
35GF Score

Get the complete analysis for STU:0IT

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.00
Price